Revenue Cycle and Payer News – April 3, 2024
Reported payers and health insurance industry news from Xsolis, AHIP, Humana, Independence Blue Cross, CVS Health, Blue Cross and Blue Shield, CareSource, and more.
Read MoreReported payers and health insurance industry news from Xsolis, AHIP, Humana, Independence Blue Cross, CVS Health, Blue Cross and Blue Shield, CareSource, and more.
Read MoreReported payers and health insurance industry news from Highmark Health, Humana, Independence Blue Cross, CVS Health, Blue Cross and Blue Shield, UnitedHealth Group, Cigna, Cambia Health Solutions, and more.
Reported payers and health insurance industry news from Amerihealth, Keystone First, L.A. Care Health Plan, Inland Empire Health Plan, Sutter Health, Pennie, The Cigna Group, Aetna, IBX, Blue Cross Blue Shield, Humana, UnitedHealthcare, and more.
By Mark Spinner – Every year, Americans are bombarded with financial advice like “sock away 12 months of living expenses.” But guidance like this feels increasingly tone-deaf when someone is hit with a $1,000 emergency room bill — and they don’t have the funds to pay it.
By Matt Bridge – Finance leaders are battling the rising denial headwinds that threaten to derail the progress healthcare organizations have made toward stabilizing revenues after years of operating in the red. For many, the solution is an optimization of financial clearance and other patient access processes.
Latest news being reported on payers and the health insurance industry including news from American Gastroenterological Association, UnitedHealthcare, Cigna, Independence Blue Cross, CVS Health, UnitedHealth Group, BCBSA, Humana, AMA and more.
By Jeffry A. Peters – In the evolving landscape of healthcare, hospitals continue to grapple with financial challenges, often operating on razor-thin margins of less than 2%. A significant factor contributing to these financial woes is the losses incurred by employed physician practices.
By Belinda Cridge & Krithika Srivats – Facing both revenue and expense issues and exasperated by clinician shortages, hospitals are increasingly noting denials in the danger zone. “Danger zone” translation: Denials are increasingly higher than 10%, costing significant dollars in lost or delayed reimbursements.
By Dr. Benjamin Barlow – The urgent care industry has faced unprecedented challenges and opportunities in the past few years due to the COVID-19 pandemic and its aftermath. Urgent care clinics have seen fluctuations in visit volumes and changes in acuity of care against the backdrop of evolving patient expectations.